Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).
Lincoff AM, Kleiman NS, Kottke-Marchant K, Maierson ES, Maresh K, Wolski KE, Topol EJ. Lincoff AM, et al. Among authors: wolski ke. Am Heart J. 2002 May;143(5):847-53. doi: 10.1067/mhj.2002.122173. Am Heart J. 2002. PMID: 12040347 Clinical Trial.
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
Cura FA, Roffi M, Pasca N, Wolski KE, Lincoff AM, Topol EJ, Lauer MS; Global Use of Strategies to Open Occluded Arteries V investigators. Cura FA, et al. Among authors: wolski ke. Am J Cardiol. 2004 Oct 1;94(7):859-63. doi: 10.1016/j.amjcard.2004.06.018. Am J Cardiol. 2004. PMID: 15464665 Clinical Trial.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page